A recent study has demonstrated that decreasing expression of polyQ-expanded ataxin-7 by 50 percent results in a full phenotypic rescue in a conditional SCA-7 mouse model (Furrer et al., 2013), which suggests that modest reduction of polyQ proteins may suffice for therapeutic intervention in humans. The gene discussed is ATXN7; the disease is spinocerebellar ataxia 7.